Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.80)
# 514
Out of 5,096 analysts
362
Total ratings
41.8%
Success rate
23.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Reiterated: Buy | $13 | $6.95 | +87.05% | 1 | Nov 3, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $19.59 | +104.19% | 9 | Nov 2, 2026 | |
| IMRX Immuneering | Reiterated: Buy | $14 | $3.49 | +301.15% | 5 | Oct 30, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.07 | +741.12% | 17 | Oct 30, 2026 | |
| VSTM Verastem | Reiterated: Buy | $18 | $9.59 | +87.70% | 15 | Oct 27, 2026 | |
| TARA Protara Therapeutics | Reiterated: Buy | $27 | $2.41 | +1,020.33% | 19 | Oct 26, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Reiterated: Buy | $10 | $1.85 | +440.54% | 15 | Oct 23, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Buy | $4 | $1.45 | +175.86% | 16 | Oct 16, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $9.11 | +448.85% | 14 | Oct 16, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $15 | $7.95 | +88.68% | 27 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $13.10 | +190.08% | 15 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $5 | $2.13 | +134.74% | 10 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.12 | +183.25% | 16 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $66.28 | +88.59% | 13 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $3.92 | +794.00% | 20 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $70 | $42.91 | +63.13% | 33 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $1 | $0.1792 | +458.04% | 12 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $6.03 | +198.51% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $22 | $14.05 | +56.58% | 21 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.84 | +212.50% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $61.96 | +61.39% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.76 | +85.87% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $1.05 | +280.95% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $4.09 | n/a | 11 | Nov 11, 2024 |
Arvinas
Nov 3, 2026
Reiterated: Buy
Price Target: $13
Current: $6.95
Upside: +87.05%
Immunome
Nov 2, 2026
Reiterated: Buy
Price Target: $40
Current: $19.59
Upside: +104.19%
Immuneering
Oct 30, 2026
Reiterated: Buy
Price Target: $14
Current: $3.49
Upside: +301.15%
NovaBridge Biosciences
Oct 30, 2026
Reiterated: Buy
Price Target: $9
Current: $1.07
Upside: +741.12%
Verastem
Oct 27, 2026
Reiterated: Buy
Price Target: $18
Current: $9.59
Upside: +87.70%
Protara Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $27
Current: $2.41
Upside: +1,020.33%
Zentalis Pharmaceuticals
Oct 23, 2026
Reiterated: Buy
Price Target: $10
Current: $1.85
Upside: +440.54%
enGene Therapeutics
Oct 16, 2026
Reiterated: Buy
Price Target: $4
Current: $1.45
Upside: +175.86%
Sutro Biopharma
Oct 16, 2026
Reiterated: Buy
Price Target: $50
Current: $9.11
Upside: +448.85%
ImmunityBio
Oct 15, 2026
Reiterated: Buy
Price Target: $15
Current: $7.95
Upside: +88.68%
Oct 12, 2026
Reiterated: Buy
Price Target: $38
Current: $13.10
Upside: +190.08%
Oct 2, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $2.13
Upside: +134.74%
Sep 30, 2026
Reiterated: Buy
Price Target: $23
Current: $8.12
Upside: +183.25%
Sep 21, 2026
Reiterated: Buy
Price Target: $125
Current: $66.28
Upside: +88.59%
Sep 15, 2026
Reiterated: Buy
Price Target: $35
Current: $3.92
Upside: +794.00%
Sep 15, 2026
Reiterated: Buy
Price Target: $65 → $70
Current: $42.91
Upside: +63.13%
Sep 9, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.1792
Upside: +458.04%
Aug 12, 2026
Reiterated: Buy
Price Target: $24 → $18
Current: $6.03
Upside: +198.51%
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $14.05
Upside: +56.58%
Aug 10, 2026
Reiterated: Buy
Price Target: $12
Current: $3.84
Upside: +212.50%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $61.96
Upside: +61.39%
Aug 4, 2026
Reiterated: Buy
Price Target: $20
Current: $10.76
Upside: +85.87%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $1.05
Upside: +280.95%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $4.09
Upside: n/a